Singlera Genomics is a fast growing company focusing on non-invasive genetic testing.
Singlera Genomics has raised $44.9M in total funding. The most recent round was Series B. The last funding was announced in June 2022.
Singlera Genomics's investors include Lilly Asia Ventures, DT Capital Partners, CICC, Green Pine Capital Partners, Junci Investment.
Singlera Genomics is headquartered in La Jolla, United States.
Singlera Genomics is a fast growing company focusing on non-invasive genetic testing.
Singlera Genomics is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Singlera Genomics — Funding & Investors." VCBacked, June 8, 2022, https://www.vcbacked.co/company/singlera-genomics. Accessed September 30, 2026.
VCBacked. (2022). Singlera Genomics — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/singlera-genomics
{{cite web |title=Singlera Genomics — Funding & Investors |url=https://www.vcbacked.co/company/singlera-genomics |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated